Feb 24, 2025 4:30pm EST MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
Feb 04, 2025 8:51am EST MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
Jan 07, 2025 9:12am EST MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications
